Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/981
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStockigt, Jim R.-
dc.date.accessioned2017-02-17T02:44:12Z-
dc.date.available2017-02-17T02:44:12Z-
dc.date.issued2007-05-
dc.identifier.citationMed J Aust. 2007 May 7;186(9):484.en_US
dc.identifier.issn0025-729Xen_US
dc.identifier.issn1326-5377en_US
dc.identifier.urihttp://hdl.handle.net/11434/981-
dc.description.abstractIn reply: It is encouraging that Donohoo, on behalf of MIMS, supports initiatives to more regularly update product information (PI). My review1 demonstrates that necessity. The material published by MIMS is apparently not under their direct editorial control; it depends on PI from the pharmaceutical industry, vetted by the Therapeutic Goods Administration.en_US
dc.publisherAustralasian Medical Publishing Companyen_US
dc.subjectPIen_US
dc.subjectPharmaceutical Industryen_US
dc.subjectTherapeutic Goods Administrationen_US
dc.subjectTGAen_US
dc.subjectDrug Informationen_US
dc.subjectProduct Informationen_US
dc.subjectObstetrics and Gynaecology Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.subjectDepartment of Endocrinology and Diabetes, Epworth HealthCare, Victoria, Australiaen_US
dc.subjectUroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleThe National Prescribing Service should lead.en_US
dc.typeLetteren_US
dc.identifier.journaltitleMedical Journal of Australiaen_US
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/17484717en_US
dc.description.affiliatesMonash University, Melbourne, VIC.en_US
dc.type.studyortrialCohort Studyen_US
dc.type.contenttypeTexten_US
Appears in Collections:Health Administration

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.